JP2011037832A5 - - Google Patents

Download PDF

Info

Publication number
JP2011037832A5
JP2011037832A5 JP2010141370A JP2010141370A JP2011037832A5 JP 2011037832 A5 JP2011037832 A5 JP 2011037832A5 JP 2010141370 A JP2010141370 A JP 2010141370A JP 2010141370 A JP2010141370 A JP 2010141370A JP 2011037832 A5 JP2011037832 A5 JP 2011037832A5
Authority
JP
Japan
Prior art keywords
formulations
active compounds
suppository
starch
gum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010141370A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011037832A (ja
Filing date
Publication date
Priority claimed from IT001109A external-priority patent/ITMI20091109A1/it
Application filed filed Critical
Publication of JP2011037832A publication Critical patent/JP2011037832A/ja
Publication of JP2011037832A5 publication Critical patent/JP2011037832A5/ja
Pending legal-status Critical Current

Links

JP2010141370A 2009-06-23 2010-06-22 酢酸バゼドキシフェンの多形フォームd及びその製造方法 Pending JP2011037832A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001109A ITMI20091109A1 (it) 2009-06-23 2009-06-23 Forma polimorfa d di bazedoxifene acetato e metodi per la sua preparazione

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015237242A Division JP2016033165A (ja) 2009-06-23 2015-12-04 酢酸バゼドキシフェンの多形フォームd及びその製造方法

Publications (2)

Publication Number Publication Date
JP2011037832A JP2011037832A (ja) 2011-02-24
JP2011037832A5 true JP2011037832A5 (enExample) 2013-08-01

Family

ID=42035899

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2010141370A Pending JP2011037832A (ja) 2009-06-23 2010-06-22 酢酸バゼドキシフェンの多形フォームd及びその製造方法
JP2015237242A Pending JP2016033165A (ja) 2009-06-23 2015-12-04 酢酸バゼドキシフェンの多形フォームd及びその製造方法
JP2017100527A Pending JP2017137360A (ja) 2009-06-23 2017-05-22 酢酸バゼドキシフェンの多形フォームd及びその製造方法
JP2018142063A Pending JP2018162327A (ja) 2009-06-23 2018-07-30 酢酸バゼドキシフェンの多形フォームd及びその製造方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015237242A Pending JP2016033165A (ja) 2009-06-23 2015-12-04 酢酸バゼドキシフェンの多形フォームd及びその製造方法
JP2017100527A Pending JP2017137360A (ja) 2009-06-23 2017-05-22 酢酸バゼドキシフェンの多形フォームd及びその製造方法
JP2018142063A Pending JP2018162327A (ja) 2009-06-23 2018-07-30 酢酸バゼドキシフェンの多形フォームd及びその製造方法

Country Status (8)

Country Link
US (1) US8063041B2 (enExample)
EP (1) EP2445876A1 (enExample)
JP (4) JP2011037832A (enExample)
AR (1) AR077203A1 (enExample)
CA (1) CA2766618A1 (enExample)
IT (1) ITMI20091109A1 (enExample)
TW (1) TW201102378A (enExample)
WO (1) WO2010151541A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI577285B (zh) 2007-08-13 2017-04-11 孟山都科技有限責任公司 控制植物寄生性線蟲的化合物及方法以及被覆有該化合物之種子
EP2616463A4 (en) * 2010-09-14 2014-01-08 Reddys Lab Ltd Dr PREPARATION OF CRYSTALLINE BAZEDOXIFES AND THEIR SALTS
WO2013182169A1 (en) 2012-06-07 2013-12-12 Zentiva, K. S. Process of preparation of an antioxidant-free polymorphically and chemically stable formulation of bazedoxifene acetate
WO2013182170A1 (en) 2012-06-07 2013-12-12 Zentiva, K. S. Enhancement of dissolution rate from pharmaceutical composition comprising bazedoxifene acetate
UA118254C2 (uk) 2012-12-04 2018-12-26 Монсанто Текнолоджи Ллс Нематоцидні водні композиції концентрату суспензії
CN103864664A (zh) * 2012-12-18 2014-06-18 江苏柯菲平医药有限公司 巴多昔芬乙酸盐新晶型及其制备方法
CN103864665B (zh) * 2014-03-04 2016-03-02 苏州特瑞药业有限公司 醋酸巴多昔芬的制备方法
CN104370796B (zh) * 2014-11-21 2016-09-14 扬子江药业集团有限公司 一种醋酸巴多昔芬多晶型b的制备方法
JP6863547B2 (ja) 2015-06-18 2021-04-21 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
GEP20217243B (en) 2015-06-18 2021-04-26 Sprl Estetra Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
KR20190096462A (ko) 2018-01-08 2019-08-20 (주)휴온스 바제독시펜 아세테이트 결정형 d형을 포함하는 안정성이 증가된 약제학적 조성물 및 그 제조방법
JOP20200260A1 (ar) * 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN109851547B (zh) * 2018-12-27 2020-09-08 北京鑫开元医药科技有限公司 一种醋酸巴多昔芬晶型d的制备方法及用途
KR20190132311A (ko) 2019-11-15 2019-11-27 (주)휴온스 바제독시펜 아세테이트 결정형 d형을 포함하는 안정성이 증가된 약제학적 조성물 및 그 제조방법
CN111004165A (zh) * 2019-12-03 2020-04-14 南京正济医药研究有限公司 一种醋酸巴多昔芬晶型a的制备方法
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
US11246874B1 (en) 2021-04-20 2022-02-15 Oxygen Biotech LLC Treatment of COVID-19
CN113244240A (zh) * 2021-05-26 2021-08-13 深圳市人民医院 醋酸巴多昔芬在治疗急性髓系白血病药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2772508A (en) 1954-04-28 1956-12-04 Claude A Greenlee Fish line pullaway sinker
ATE206701T1 (de) 1996-04-19 2001-10-15 American Home Prod Östrogene verbindungen
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
AR029538A1 (es) 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
NZ537051A (en) 2002-06-13 2007-11-30 Wyeth Corp Use of bazedoxifene in an extended dosage treatment regimen
JP2007532560A (ja) * 2004-04-07 2007-11-15 ワイス バゼドキシフェンアセテートの結晶多形
TW200536845A (en) * 2004-04-07 2005-11-16 Wyeth Corp Crystalline polymorph of bazedoxifene acetate
MXPA06011685A (es) * 2004-04-08 2006-12-14 Wyeth Corp Formulaciones de dispersiones solidas de acetato de bazedoxifeno.
CN101304731B (zh) 2005-08-24 2012-06-20 惠氏公司 醋酸苯卓昔芬制剂及其生产方法
CZ302358B6 (cs) * 2007-07-25 2011-03-30 Zentiva, A. S. Nové soli bazedoxifenu

Similar Documents

Publication Publication Date Title
JP2011037832A5 (enExample)
JP2021001196A5 (enExample)
JP2010047612A5 (enExample)
JP2015518885A5 (enExample)
JP2007238637A5 (enExample)
JP2009537478A5 (enExample)
FI4159205T3 (fi) Uudenlainen farmaseuttinen koostumus
JP2006516570A5 (enExample)
JP2018507200A5 (enExample)
MX2009009703A (es) Preparacion solida que comprende 2-[[6-[(3r)-3-amino-1-piperidinil ]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-4-fluoro benzonitrilo.
JP2010132654A5 (enExample)
UA116334C2 (uk) Тверді форми дозування бендамустину
JP2015521191A5 (enExample)
JP2011026335A5 (enExample)
JP2014221827A5 (enExample)
JP2019526591A5 (enExample)
CN103751139A (zh) 鲁拉西酮口腔崩解片
JP2008516004A5 (enExample)
JP2007197357A5 (enExample)
RU2016130602A (ru) Твердые препараты, содержащие тофоглифлозин, и способ их получения
MY139086A (en) Use of debranched starch in extrusion-spheronization pharmaceutical pellets
JP2015129175A5 (enExample)
JP2017002092A5 (enExample)
JP2017537883A5 (enExample)
HRP20170571T1 (hr) Tableta koja sadrži 5-hidroksi-1h-imidazol-4-karboksamid